M. Kelly Nicholas

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Henry S. Friedman, Michael D. Prados, Patrick Y. Wen et al. · Journal of Clinical Oncology · 2009 · 2.4K citations

Medicine, Oncology, Pharmacology +17

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

Yu Liang, Maximilian Diehn, Nathan P. Watson et al. · Proceedings of the National Academy of Sciences · 2005 · 502 citations · Full text

Medicine, Neuroscience, Oncology +17

A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study1

Michael D. Prados, Kathleen R. Lamborn, W. K. Alfred Yung et al. · Neuro-Oncology · 2006 · 256 citations · Full text

Medicine, Oncology, Pharmacology +17

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Henry S. Friedman, Michael D. Prados, Patrick Y. Wen et al. · Journal of Clinical Oncology · 2023 · 183 citations

Medicine, Oncology, Pharmacology +17

Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival.

Ralph P. Ermoian, C. Sloane Furniss, Kathleen R. Lamborn et al. · PubMed · 2002 · 180 citations

Medicine, Oncology, Pathology +17